Cathérine Boileau|Vinh?Kim Nguyen|Mohamed Sylla|Nimâ Machouf|Annie Chamberland|H Traore|P. Niamba|I Diallo|M Y Maïga|Mamadou Cissé|S. Rashed|Cécile Tremblay
Low Prevalence of Detectable HIV Plasma Viremia in Patients Treated With Antiretroviral Therapy in Burkina Faso and Mali
McGill University Health Centre|Centre Pour le Développement des Vaccins-Mali|Université de Montréal|Université de Montréal|Université de Montréal|Centre Hospitalier Universitaire Yalgado Ouédraogo|Centre Pour le Développement des Vaccins-Mali|Université de Montréal|Centre Hospitalier Universitaire Yalgado Ouédraogo|Centre Hospitalier Universitaire Yalgado Ouédraogo|McGill University Health Centre|Centre Pour le Développement des Vaccins-Mali|Université de Montréal|Université de Montréal|Université de Montréal
subsaharan africa seen dramatic increases numbers people treated antiretroviral therapy art although standard art regimens universally applied viral load measurement currently part standard monitoring protocols subsaharan africawe describe prevalence inadequate virological response ivr art viral load 500 copiesml identify factors associated outcome 606 hivpositive patients treated least 6 months recruitment took place 7 hospitals communitybased sites bamako ouagadougou information collected using medical charts interviewsthe overall prevalence ivr treatmentnaive patients 123 244 pretreated patients differences rates ivr according art delivery sites time treatment patients living farther away odds ratio 248 95 confidence interval ci 140 439 protease inhibitor nucleoside reverse transcriptase inhibitor regimens 323 95 ci 179 582 reporting treatment interruptions 236 95 ci 135 415 increased odds ivr immune suppression 332 95 ci 194 570 poor selfrated health 200 95 ci 117 341 also associated ivrsufficient expertise dedication exist public hospital communitybased programs achieve rates treatment success comparable betterresourced settings